Linked Data API

Show Search Form

Search Results

833993
star this property registered interest false more like this
star this property date less than 2018-01-30more like thismore than 2018-01-30
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Social Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when his Department plans to publish its consultation on adult social care. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 125750 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-02-07more like thismore than 2018-02-07
star this property answer text <p>The Government has committed to publishing a Green Paper by summer 2018, setting out its proposals for reform.</p><p> </p><p>In developing the Green Paper, it is right that we take the time needed to debate the many complex issues and listen to the perspectives of experts and care users, building consensus around reforms which can succeed. This is why we are starting a process of initial engagement over the coming months through which the Government will work with experts, stakeholders and users to shape the long-term reforms that will be proposed in the Green Paper.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2018-02-07T14:20:13.683Zmore like thismore than 2018-02-07T14:20:13.683Z
star this property answering member
4008
star this property label Biography information for Dame Caroline Dinenage more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
838969
star this property registered interest false more like this
star this property date less than 2018-02-08more like thismore than 2018-02-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Surgical Mesh Implants more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will immediately suspend the use of medical procedures involving vaginal mesh implants. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 127530 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-02-26more like thismore than 2018-02-26
star this property answer text <p>The Government does not support a suspension or ban of the use of surgical mesh devices. The view of the Medicines and Healthcare products Regulatory Agency (MHRA) is that surgical mesh devices are acceptably safe when used as intended and as part of an appropriate treatment pathway where the associated risk and benefits are considered, and where surgical mesh devices conform to the requirements of the current legislation in the European Union.</p><p> </p><p>As a Department we are committed to improving the outcomes for all patients involved. We continue to work closely with MHRA, NHS England, the National Institute for Health and Care Excellence and professional bodies. MHRA continue to review available evidence to ensure our regulatory position is up to date, liaising with EU partners and non-EU regulators.</p><p> </p><p> </p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2018-02-26T16:17:21.167Zmore like thismore than 2018-02-26T16:17:21.167Z
star this property answering member
4065
star this property label Biography information for Dame Jackie Doyle-Price more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
867044
star this property registered interest false more like this
star this property date less than 2018-03-19more like thismore than 2018-03-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Pharmaceutical Price Regulation Scheme more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress his Department has made on negotiating a new Pharmaceutical Price Regulation Scheme. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 133162 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-27more like thismore than 2018-03-27
star this property answer text <p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin during 2018.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-27T11:48:24.473Zmore like thismore than 2018-03-27T11:48:24.473Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
873628
star this property registered interest false more like this
star this property date less than 2018-03-28more like thismore than 2018-03-28
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Spondyloarthritis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the monitoring of individual Quality Statement measures in the NICE Quality Standard on Spondyloarthritis, to be published in June 2018. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 134742 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-17more like thismore than 2018-04-17
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) quality standards are concise sets of statements designed to drive quality improvements within a particular area of care and cover the National Health Service, public health and social care. They are derived from the best available evidence, normally NICE guidance but also other sources of NICE-accredited guidance, and are developed by NICE in collaboration with health and social care professionals, their partners and service users. The Department does not have any arrangements for monitoring the uptake of NICE quality standards centrally as they are not mandatory, although health and care commissioners are expected to take them fully into account.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-04-17T14:04:58.22Zmore like thismore than 2018-04-17T14:04:58.22Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
873629
star this property registered interest false more like this
star this property date less than 2018-03-28more like thismore than 2018-03-28
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Arthritis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the Rheumatoid and Early Inflammatory Arthritis Annual Report; and whether that report will include additional data collection for spondyloarthritis patients. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 134743 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-17more like thismore than 2018-04-17
star this property answer text <p>In August 2017, a new three year Rheumatoid and Early Inflammatory Arthritis Audit was commissioned by the Healthcare Quality Improvement Partnership (HQIP). HQIP manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England.</p><p> </p><p>The British Society for Rheumatology was awarded the contract to run the audit, which will assess the care provided by rheumatology services in England and Wales, and the health outcomes this achieves for people living with inflammatory arthritis conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.</p><p> </p><p>Building on the previous audit, which ran from 2014-16, it will provide more focused and precise data and employ real-time feedback to support local quality improvement. The audit is expected to launch in May this year, with first reports expected in the autumn of 2019. More information can be found at the following link:</p><p> </p><p><a href="http://www.rheumatology.org.uk/Knowledge/Excellence/Audits" target="_blank">www.rheumatology.org.uk/Knowledge/Excellence/Audits</a></p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-04-17T13:59:58.94Zmore like thismore than 2018-04-17T13:59:58.94Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
882155
star this property registered interest false more like this
star this property date less than 2018-04-13more like thismore than 2018-04-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Pharmaceutical Price Regulation Scheme more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the timetable for negotiations on the new pharmaceutical price regulation scheme is; and if he will make a statement. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 135214 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-19more like thismore than 2018-04-19
star this property answer text <p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin shortly.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-04-19T11:28:11.54Zmore like thismore than 2018-04-19T11:28:11.54Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
882668
star this property registered interest false more like this
star this property date less than 2018-04-13more like thismore than 2018-04-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Rare Diseases more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether the Government plans to continue to participate in the European Reference Networks for patients with complex or rare medical conditions after the UK leaves the EU and the expiry of the implementation period. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 135730 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-19more like thismore than 2018-04-19
star this property answer text <p>The Government has noted the importance of continued collaboration with European partners in the 2017 policy paper ‘Collaboration on Science and Innovation: A Future Partnership Paper’. European Reference Networks (ERNs) for rare diseases patients were cited in the paper as an example of collaboration that the United Kingdom and European Union should discuss in the negotiations, given the mutual benefit.</p><p> </p><p>The Government has set out three key principles in developing a new regulatory system post EU exit: patients should not be disadvantaged; innovators should be able to get their products into the UK market as quickly and simply as possible; and we continue to play a leading role promoting public health. The Government will be guided by these principles in its negotiations with EU partners.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2018-04-19T14:12:32.767Zmore like thismore than 2018-04-19T14:12:32.767Z
star this property answering member
4008
star this property label Biography information for Dame Caroline Dinenage more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
964649
star this property registered interest false more like this
star this property date less than 2018-09-03more like thismore than 2018-09-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Medical Treatments: Innovation more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress his Department has made on establishing an Accelerated Access Collaborative to manage the new accelerated access pathway. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 169360 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-11more like thismore than 2018-09-11
star this property answer text <p>The Accelerated Access Collaborative (AAC) has been successfully established, meeting for the first time in January 2018 and agreeing terms of reference and ways of working. Lord Darzi is the new chair of the AAC, replacing Sir Andrew Witty, who stood down to avoid any conflict of interest with his new role as CEO of Optum. We expect that the Accelerated Access Pathway will launch at the next meeting of the AAC, which will be in the autumn.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-09-11T14:37:19.627Zmore like thismore than 2018-09-11T14:37:19.627Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
964650
star this property registered interest false more like this
star this property date less than 2018-09-03more like thismore than 2018-09-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Medical Treatments: Innovation more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when the accelerated access pathway is planned to begin designating breakthrough products. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 169361 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-11more like thismore than 2018-09-11
star this property answer text <p>The Accelerated Access Collaborative will meet this autumn to launch the Accelerated Access Pathway and the first group of products will be part of their discussions.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-09-11T14:35:39.31Zmore like thismore than 2018-09-11T14:35:39.31Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
1054678
star this property registered interest false more like this
star this property date less than 2019-02-04more like thismore than 2019-02-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Autism: Care Homes more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how much the NHS spent on private contractors for residential care for patients with a diagnosis of autism in (a) 2016-17 and (b) 2017-18. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 216285 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-02-12more like thismore than 2019-02-12
star this property answer text <p>The information requested is not held centrally.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-02-12T12:03:12.103Zmore like thismore than 2019-02-12T12:03:12.103Z
star this property answering member
4008
star this property label Biography information for Dame Caroline Dinenage more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this